Day: September 3, 2025

Verkkokauppa.com Oyj strengthens its management team and appoints a new Chief Supply Chain Officer  Verkkokauppa.com Oyj STOCK EXCHANGE RELEASE 3 September 2025 at 03:00 p.m. EESTAnne-Mari Paapio (MSc) has been appointed Chief Supply Chain Officer of Verkkokauppa.com. She most recently served as Vice President of Procurement and Category Management at Valio Aimo, where she drove strategic initiatives in sourcing and category development. Prior to that, she led consulting projects as a Project Leader at Boston Consulting Group. She has strong strategic supply chain management expertise and a solid background in customer-centric operations within retail. Anne-Mari will report to the CEO and become a member of the management team. She will start in the new position on 10 September 2025.   CEO Panu Porkka: “I am pleased to welcome...

LONG BEACH, Calif. and TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) — Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest-growing, vertically-integrated cannabis companies in the U.S., today announced with great sadness the passing of Mr. George Raveling, a valued member of the Company’s Board of Directors and the Glass House family. Mr. Raveling joined the Board in 2021 when the company went public, bringing with him extensive experience in marketing and corporate governance. As an inductee of the Naismith Basketball Hall of Fame and the College Basketball Hall of Fame for his coaching career accomplishments and having been Nike’s Director of International Basketball, Mr. Raveling brought immeasurable leadership to...

EDINBURGH, United Kingdom, Sept. 03, 2025 (GLOBE NEWSWIRE) — NuCana plc (Nasdaq: NCNA) (“NuCana” or the “Company”) announced a presentation at the upcoming annual European Society for Medical Oncology (“ESMO”) congress being held October 17-21, 2025 in Berlin, Germany (the “ESMO Congress 2025”). The details of NuCana’s presentation at the meeting are as follows: Abstract Title: Patient Derived Organoids Reveal Synergy Between NUC-7738 and PD-1 Inhibition in Renal Cell Cancer Poster Number: 1530PSession: Investigational ImmunotherapyDate: Sunday, October 19, 2025Presenting Author: H. Abdullah All regular abstracts accepted for presentation at the ESMO Congress 2025 will be published online via the ESMO website on Monday, October 13 at 6:05 p.m. ET (12:05 a.m. CEST). All accepted abstracts will be published online in the ESMO Congress...

10-minute home test detects early kidney damage in diabetic and hypertensive patients Hypertension affects roughly one-third of adults in the UAE Diabetes impacts approximately one in four UAE nationalsIRVINE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic solutions, announced today announced that the United Arab Emirates (UAE) Ministry of Health and Prevention has approved its Fortel® Kidney Test for home use. This important regulatory milestone expands access to accurate, easy-to-use diagnostic tools supporting early identification of kidney damage in high-risk populations. The Fortel® Kidney Test is a rapid, 10-minute easy to use diagnostic test that detects low levels of albumin in urine, a critical early marker of kidney disease. The test is particularly...

Atlanta, GA, Sept. 03, 2025 (GLOBE NEWSWIRE) — ScanTech AI Systems Inc. (the “Company” or “ScanTech AI”) (Nasdaq: STAI), a next-generation provider of AI-powered CT screening systems for aviation, customs, and critical infrastructure, today announced a consultancy agreement with FSR Group Pte. Ltd. (“FSR Capital”) to provide specialized advisory services in capital markets, Nasdaq compliance, and SEC reporting. This forward-looking initiative highlights ScanTech AI’s proactive commitment to resolving ongoing regulatory challenges, enhancing investor confidence, and positioning the Company for sustained growth in a competitive market. FSR Capital brings a team with a proven track record of success in navigating Nasdaq compliance issues for public companies, including bid price deficiencies and filing delays,...

REDWOOD CITY, Calif./BELFAST, Northern Ireland, Sept. 03, 2025 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), an innovative medical technology company specializing in remote cardiac monitoring solutions, and B-Secur, a leader in ECG algorithm and biosensing technology, are transforming the consumer wearables market with an enhancement to their joint cardiac monitoring platform. The device-neutral platform, which launched in early 2025 for ambulatory cardiac monitoring, will now support ECG data from consumer wearables. This advancement enables the seamless integration and review of user data collected from smartwatches, smart rings, fitness trackers, and other mobile health products within Biotricity’s cloud-based medical workflow.  The move solidifies Biotricity and B-Secur’s leadership in digital cardiovascular innovation,...

LAKE FOREST, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) announced that members of its management team will host investor meetings at two investor conferences in New York City during September 2025. Company management will host investor meetings at the HC Wainwright Conference on Wednesday, September 10, 2025, taking place at the Lotte New York Palace Hotel. Investors can register and request meetings via their HC Wainwright representative. The Company will also participate in investor meetings at the Lake Street Capital Markets BIG9 Conference, taking place September 11, 2025 at the Yale Club New York City. Investors can register and request meetings through their Lake Street representative. About Assertio Assertio is a pharmaceutical company with comprehensive commercial...